Document Detail


Treatment patterns in inpatients with bipolar disorder at a psychiatric university hospital over a 9-year period: focus on mood stabilizers.
MedLine Citation:
PMID:  22842799     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The increasing number of pharmacological treatment options for bipolar disorder seems to be paralleled by the number of evidence-based guidelines published previously. The aim of this study was to systematically examine the adherence to published guidelines and any change in prescription habits over time in a psychiatric hospital setting. This is a retrospective study of 531 bipolar in patients who were consecutively admitted to the Department for Psychiatry and Psychotherapy in Innsbruck. Their complete medical histories were evaluated for psychotropic medications, with a special focus on mood stabilizers (MSs). To compare the use of individual MSs or combinations with other psychotropic medications in two preselected observation periods (1999-2003 and 2004-2007), we used Fisher's exact test. Overall, the proportion of patients receiving at least one MS increased significantly from 1999-2003 to 2004-2007 (74.1 vs. 83.1%, P=0.011). Among the individual MSs, valproate was used most frequently in both time periods, showing a significant increase (P<0.001). Prescriptions of quetiapine (P<0.001) and lamotrigine (P=0.033) increased significantly, carbamazepine showed a significant decrease (P<0.001). Prescriptions of lithium and olanzapine decreased without reaching significance. The significant increase in the prescription of MS reflects the increasing awareness and implementation of recent evidence-based medicine guidelines into clinical practice. Clinical decision making, usually made on the basis of individual clinical experience, should always be reevaluated using periodically updated evidence-based medicine guidelines.
Authors:
Michaela Walpoth-Niederwanger; Georg Kemmler; Heinz Grunze; Ulrike Wei; Christine Hörtnagl; Robert Strau; Imrich Blasko; Armand Hausmann
Related Documents :
22145759 - The medical-industrial complex, professional medical associations, and continuing medic...
21719769 - Withdrawal of antithrombotic agents and its impact on ischemic stroke occurrence.
24591839 - Feasibility of a self-administered survey to identify primary care patients at risk of ...
22165839 - Revising a medication education program on an inpatient child and adolescent psychiatri...
21795879 - Multidrug-resistant bacterial colonization of combat-injured personnel at admission to ...
21584369 - The prevalence and characterization of self-medication for obtaining pain relief among ...
19386019 - Off-label use in dermatology in germany: what has changed since 2004.
19467169 - Competition and compromise in negotiating the new governance of medical performance: th...
7897729 - Poor hospital documentation of violence against women.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-26
Journal Detail:
Title:  International clinical psychopharmacology     Volume:  -     ISSN:  1473-5857     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8609061     Medline TA:  Int Clin Psychopharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
aDepartment of Psychiatry and Psychotherapy, Innsbruck Medical University, Innsbruck, Austria bInstitute of Neuroscience, Academic Psychiatry, Newcastle General Hospital, Newcastle University, Newcastle upon Tyne, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effects of simvastatin on hippocampal caspase-3 and Bcl-2 expression following kainate-induced s...
Next Document:  Ru-catalyzed hydrogenation of 3,5-diketo amides: simultaneous control of chemo- and enantioselectivi...